-24.4%
DRUG price history and return analytics
+63.2%
-87.7%
-97.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | VT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.4% | -3.5% | +2.0% | -1.6% |
| 7D | -11.7% | -8.5% | -3.2% | -12.2% |
| 30D | -59.6% | -10.4% | -49.1% | -59.9% |
| 3M | -74.0% | -10.9% | -63.1% | -74.2% |
| 6M | -75.4% | -7.5% | -67.8% | -75.5% |
| YTD | -73.9% | +1.6% | -75.4% | -73.7% |
| 1Y | -64.5% | +7.2% | -71.7% | -63.7% |
| 3Y | +1,532.0% | +53.2% | +1,478.8% | +1,324.0% |
| 5Y | -18.7% | +45.0% | -63.7% | -30.5% |
| All | -24.4% | +63.2% | -87.7% | -24.8% |
Cumulative growth
Daily Returns
Daily percentage return beside VT.
Daily Out/Under-Performance
Portfolio return minus VT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded VT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling